Company intelligence / Profile preview
Yunnan Shengke Pharmaceutical
Kunming, Yunnan, Chinahys.cn ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Yunnan Shengke Pharmaceutical is a private pharmaceutical company based in Kunming, Yunnan Province, China. It focuses on the development and commercialization of herbal medicines. Its lead product, SanQi LongXueJie Capsule, is approved in China for cardiovascular diseases. The company has also published preclinical results showing efficacy of a compound ("4b") as an inhibitor of colitis in animal models. There is no evidence of large-scale clinical trials or multiple late-stage assets.
- Therapeutic areas
- GastroenterologyCardiovascular
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Yunnan Shengke Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yunnan Shengke Pharmaceutical.